Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Intimation for Board Meeting To Be Held On Thursday, November 12, 2020.

MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2020 ,inter alia, to consider and approve the Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2020.
04-11-2020
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Shareholding for the Period Ended September 30, 2020

Mangalam Drugs & Organics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here
19-10-2020
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Certificate Under Regulation 40(9) / 40(10) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended September 30, 2020.

Pursuant to Regulation 40(9)/40(10) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose the certificate for the half year ended September 30, 2020 issued by CS Sandeep Gandhi - Practicing Company Secretary.
15-10-2020
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Compliance Certificate- Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

We hereby enclosed herewith the Compliance Certificate under Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, duly signed by the Compliance Officer of the Company and Authorised Representative of Link Intime India Private Limited (RTA) for the half year ended September 30, 2020.
13-10-2020
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Statement Of Investor Complaints For The Quarter Ended September 2020

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Geeta KariraDesignation :- Company Secretary and Compliance Officer
08-10-2020
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Closure of Trading Window

Intimation of closure of Trading Window
30-09-2020
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Mangalam Drugs & Organics Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
28-09-2020
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Pursuant to Regulation 44(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the voting results of the business transacted at the 47th Annual General Meeting (AGM) of the Company along with Scrutinizer's Report.
27-09-2020
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Shareholder Meeting / Postal Ballot-Outcome of AGM

Proceedings of the 47th Annual General Meeting (AGM) of the Company held on Friday, September 25, 2020 at 3:30 P.M. through Video Conferencing / Other Audio Visual Means
26-09-2020
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order

Intimation of material information in terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
25-09-2020
Next Page
Close

Let's Open Free Demat Account